Tirabrutinib (Velexbru)

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 00:34, 7 June 2023 by Jwarner (talk | contribs) (Created page with "==Mechanism of action== BTK inhibitor ==Diseases for which it is used== *Waldenström macroglobulinemia ==History of changes in PMDA indication== *2020-08-21: new indica...")

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Mechanism of action

BTK inhibitor

Diseases for which it is used

Waldenström macroglobulinemia

History of changes in PMDA indication

2020-08-21: new indications for the treatment of Waldenström's macroglobulinemia and lymphoplasmacytic lymphoma.

Retrieved from "https://hemonc.org/w/index.php?title=Tirabrutinib_(Velexbru)&oldid=72462"